comparemela.com
Home
Live Updates
F 2160 Jp3386370005 - Breaking News
Pages:
Latest Breaking News On - F 2160 jp3386370005 - Page 1 : comparemela.com
GNI : summary Q&A from Q1 2023 financial results analyst call and other recent inquiries
This presentation contains statements concerning the current plans, expectations, and strategies of GNI. | May 23, 2023
United states
Continent pharmaceuticals co ltd
Berkeley advanced biomaterials
Catalyst biosciences inc
Group ltd
Protein degradation
Gni group ltd stock exchange
Press release
F 2160 jp3386370005
GNI : FY2023Q1 Earnings Call Transcript
This presentation contains statements concerning the current plans, expectations, and strategies of GNI. | May 22, 2023
United states
Berkeley advanced biomaterials
Continent pharmaceuticals co ltd
Catalyst biosciences inc
Group ltd
Protein degradation
Medical device
Gni group ltd stock exchange
Press release
F 2160 jp3386370005
GNI : summary Q&A from FY2022 AGM | MarketScreener
This presentation contains statements concerning the current plans, expectations and strategies of GNI. | April 11, 2023
Ying luo
Hong kong
United states
Continent pharmaceuticals co ltd
Cullgen shanghai inc
Hong kong stock exchange
Cullgen inc
Group ltd
Catalyst biosciences inc
Berkeley advanced biomaterials
Cullgen shanghai
Protein degradation
Regarding cullgen
Beijing continent
Gni group ltd stock exchange
Press release
vimarsana © 2020. All Rights Reserved.